Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Citicoline. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110684066A reveals a greener T3P-mediated route for Citicoline Sodium, eliminating benzene and phosgene while ensuring >99% purity for reliable API intermediate supply.
Novel two-step route reduces costs and improves purity for reliable citicoline supplier manufacturing ensuring high-quality pharmaceutical intermediates and scalable production capabilities.
Novel 3-step synthesis route for Citicoline Sodium avoiding DCC. Achieves >99.5% purity with scalable, cost-effective manufacturing processes.